APL Apollo Tubes (533758) Q4 09/10 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 09/10 earnings summary
23 Oct, 2026Executive summary
FY10 consolidated net sales rose 17.34% YoY to ₹61,800.84 lakh; PAT increased to ₹2,977.50 lakh from ₹253.72 lakh.
Capacity reached 400,000 MTPA after commissioning the 200,000-MTPA Hosur facility, broadening manufacturing presence across North and South India.
Financial highlights
Consolidated EBITDA (reported as EBDITA) was ₹6,628.48 lakh versus ₹2,852.76 lakh in FY09.
Consolidated steel-tube sales volume rose to 156,584 MT from 115,214 MT; production reached 175,850 MT, up 42.46% YoY.
Outlook and guidance
Revenue target of ₹1,500 crore for FY12, with sales volume expected to rise from 1.6 lakh MT in FY10 to 4 lakh MT by FY12.
FY11 EBITDA margin target: +100 bps, supported by value-added products and scale; retail revenue mix target rises from 10% in FY11 to 18% in FY12.
A western India acquisition was expected during FY11; alternatively, a greenfield facility of similar capacity to Hosur was under consideration.
Latest events from APL Apollo Tubes
- Sales surged 55.95% as expansion advanced toward 1 million TPA by 2015.533758
Q4 11/12 - FY11 growth accelerated as capacity reached 490,000 MTPA, with 1 million MTPA targeted by 2015.533758
Q4 10/11 - Revenue and volumes climbed, but margin pressure cut PAT as expansion targets accelerate.533758
Q4 13/14 - Revenue rose 34% as production scaled up and EBITDA margin expanded to 6.92%.533758
Q4 15/16 - Revenue grew 25%, while DFT expansion targets 2 million MTPA capacity.533758
Q4 17/18 - Sales and PAT surged in FY13 as expansion targeted 1 MTPA capacity by 2015.533758
Q4 12/13 - Volume and revenue advanced, while falling steel prices drove inventory losses and margin pressure.533758
Q4 14/15 - FY20 growth and lower leverage met the COVID-19 shock with expansion plans reset toward cash preservation.533758
Q4 19/20 - FY21 growth and cash generation surged as debt fell and value-added products expanded.533758
Q4 20/21